Steth IO vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Steth IO

by STRATOSCIENTIFIC

iPredict Eye Screening

by iHealthScreen

AI Verdict

Steth IO is designed for real-time auscultation and monitoring of heart and lung sounds, enhancing physical exams and remote care for cardiac and pulmonary conditions. In contrast, iPredict Eye Screening provides AI-powered screening for retinal diseases and predicts systemic risks like stroke and heart attack through retinal imaging. While both leverage AI and telemedicine, their core diagnostic methodologies and primary target conditions are distinct, making them suitable for different clinical needs.

Choose Steth IO if…

Choose Steth IO if your primary need is real-time, high-fidelity auscultation and visualization of heart and lung sounds for diagnostic purposes or remote patient monitoring. This tool is ideal for healthcare providers requiring immediate auditory and visual feedback on cardiopulmonary function, facilitating enhanced diagnostic accuracy and seamless collaboration with specialists through shared recordings and live telemedicine capabilities.

View Steth IO →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if your focus is on efficient, AI-powered early detection of retinal diseases like AMD, Diabetic Retinopathy, and Glaucoma, especially in a primary care setting. This platform is best suited for clinics and providers looking to quickly screen patients for ocular pathologies and gain insights into systemic disease risks (stroke, heart attack) through non-invasive retinal imaging and automated analysis.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Steth IO	iPredict Eye Screening
Pricing	Customized pricing; subscription-based for steth io spot.	Contact for pricing
Deployment	Mobile app, Cloud-based system.	Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools highlight ease of use and efficiency. Steth IO leverages familiar smartphone integration for intuitive operation, while iPredict emphasizes an 'easy to operate' non-invasive process with a dedicated touchscreen interface and fast results. Without direct user feedback or detailed UI/UX comparisons, it's difficult to definitively declare one superior.

Clinical Value

iPredict Eye Screening

iPredict Eye Screening offers a broader scope of FDA-cleared AI-powered screenings for multiple serious diseases (DR, AMD, Glaucoma) with explicitly stated high accuracy metrics (e.g., ~95% average, AMD sensitivity 86.86%, specificity 94.13%). Its additional capability for systemic disease risk prediction further enhances its clinical utility compared to Steth IO's focus on auscultation enhancement.

Pricing & Value

iPredict Eye Screening

iPredict Eye Screening provides more transparent pricing with an estimated per-patient cost of $10-$20, directly linked to potential Medicare/commercial payor reimbursement (20%-40%). Steth IO's 'customized pricing' for its main offering makes a direct value comparison more challenging, despite a clear subscription for its 'Spot' version.

Enterprise Readiness

iPredict Eye Screening

iPredict Eye Screening explicitly states HIPAA compliance and offers crucial EHR and telemedicine service integration, which are fundamental for enterprise adoption. Steth IO's caveat about user responsibility for HIPAA compliance and a warning for email export raises concerns for large-scale enterprise deployment and data governance.

Innovation

iPredict Eye Screening

While Steth IO offers an innovative approach to traditional auscultation by transforming a smartphone into an FDA-cleared stethoscope with real-time visualization and digital filters, iPredict Eye Screening demonstrates a broader and deeper application of AI. It provides multi-disease screening, integrates image analysis, and offers a systemic health risk prediction system, representing a more advanced and comprehensive AI innovation in diagnostics.

Support & Docs

Steth IO

Steth IO appears to offer more readily accessible and explicit support resources, including FAQs and user manuals, directly linked on its website. While iPredict implies support through training and contact options, Steth IO's dedicated support section provides clearer documentation access.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Steth IO	iPredict Eye Screening
Product Name	Steth IO	iPredict Eye Screening
Primary Function	Smartphone stethoscope for hearing, visualizing, recording, and sharing heart and lung sounds.	AI-powered screening for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and risk prediction for systemic diseases.
Company	STRATOSCIENTIFIC	iHealthScreen
Key Specialties	Cardiology, Internal Medicine, Pulmonology	Family Medicine, Internal Medicine, Ophthalmology
Core Diagnostic Capabilities	Real-time visualization of heart and lung sounds (phonocardiogram/spectrogram); digital filters for sound enhancement and ambient noise attenuation.	AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma; Image Analyzer for Retinal Vessel, Retinal Pathology, and OCT Inspector.
Additional Features	Record and save patient exams, share exams, annotation tool, telemedicine capabilities (live auscultation, video calls, scheduling), remote patient monitoring.	Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service, Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients, fast results (test < 5 min, report < 60 sec), high accuracy (~95%).

Videos

Demos, reviews, and walkthroughs featuring Steth IO and iPredict Eye Screening.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for different patient populations or care settings?

Steth IO enhances auscultation by allowing real-time visualization, recording, and sharing of heart and lung sounds, making it suitable for remote patient monitoring, telemedicine consultations, and specialist referrals in cardiology, internal medicine, and pulmonology. iPredict Eye Screening provides rapid, AI-powered screening for retinal diseases like DR, AMD, and Glaucoma, along with systemic disease risk prediction, fitting well into primary care, ophthalmology, and telemedicine workflows for patients aged 50 and older.

What is the depth of EHR integration for each tool, and how does it facilitate data flow into patient records?

Steth IO allows sharing of patient exams with specialists or other healthcare providers, and its telemedicine platform aims to reduce duplicate patient records by consolidating the examination procedure. iPredict Eye Screening explicitly offers Electronic Health Record (EHR) Solutions and integrates with EHR systems to facilitate the flow of screening results and risk predictions directly into patient records.

What are the specific accuracy and sensitivity metrics for each tool, particularly for the conditions they screen or diagnose?

Steth IO is described as enhancing diagnostic accuracy through real-time visualization, sound enhancement, and ambient noise attenuation, and an AI tool for heart sound analysis was found to accurately recognize abnormal heart sounds 73% of the time. iPredict Eye Screening reports high accuracy, approximately 95% on average, with specific metrics for AMD showing 86.86% sensitivity and 94.13% specificity, and for glaucoma, an accuracy of 94.3% and sensitivity of 95.0%.

For which specific clinical scenarios or patient populations is each tool most effective and clinically relevant?

Steth IO is most effective for clinicians in Cardiology, Internal Medicine, and Pulmonology who need to perform, visualize, record, and share auscultation findings for heart and lung sounds, especially beneficial for telemedicine and remote patient monitoring. iPredict Eye Screening is highly relevant for Family Medicine, Internal Medicine, and Ophthalmology practices for early detection of Diabetic Retinopathy, Age-related Macular Degeneration, and Glaucoma in patients aged 50 and older, and for predicting systemic disease risks.

What is the typical learning curve for physicians and their staff to effectively use each tool in a clinical setting?

Steth IO leverages a smartphone-powered stethoscope and app, with no additional training requirements for its use, suggesting a potentially intuitive interface for users familiar with mobile devices. iPredict Eye Screening is described as easy to operate, non-invasive, and features an advanced touchscreen interface, with tests completed in less than 5 minutes and reports in under 60 seconds, indicating a minimal learning curve.

What are the key considerations for rolling out each tool across multiple clinical sites, and what is the estimated time-to-value for a new practice?

Steth IO, being a mobile app and cloud-based system with hardware, offers a 'one-click implementation' for its Telaspot platform, allowing providers to launch a virtual clinic and enroll patients quickly, with devices shipped within four days. iPredict Eye Screening, as a cloud-based Software as a Medical Device accessible in various settings, offers fast results (test under 5 minutes, report under 60 seconds), suggesting a quick time-to-value and straightforward deployment across multiple sites.